Resmed Inc at William Blair Growth Stock Conference Transcript

Jun 02, 2026 / 09:00PM GMT
Release Date Price: MXN3716.1
Brandon Vazquez
William Blair Capital Partners - Analyst

Hello, everybody. My name is Brandon Vasquez. For those who I haven't met before, I'm one of William Blair's medical device analysts also cover animal health for the firm. I am required to inform you for a complete list of research disclosures and potential conflicts of interest, go to williamblair.com.

And with that, I am happy to say that we have the ResMed team here. We have Mick Farrell, the CEO, and Aaron Bloomer, the new CFO. Happy to join us here. They're going to give us a corporate presentation as we've been doing all day.

We will actually stay in this room for the breakout session. So at the end, I'll come up here. I might give us like five minutes to let people trickle in if they're coming from another session, and then we'll do Q&A here.

With that, I'll turn it over to Mick.

Michael Farrell
Resmed Inc - Chief Executive Officer and Chairman of the Board

Thanks. And I've got the time here, so I'll stick pretty closely to the 29 minutes they got me here on the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot